- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01341028
Gut Hormones After Roux-en-Y Gastric Bypass (RYGBP) Plus Gastric Fundus Resection
Effects of the Resection of the Gastric Fundus on the Secretion of Ghrelin, Peptide-YY, Glucagon-like Peptide-1 and Insulin Secretion in Morbidly Obese Patients Undergoing Laparoscopic Roux-en-Y Gastric Bypass
- Laparoscopic Roux-en-Y gastric bypass (LRYGBP) is considered a combination of restriction-malabsorption procedure and one of the most common operative procedures implemented.
- Over the last years increasing evidence suggests that the beneficial effects of bariatric operations might be related to the suppression of appetite caused by the release of the anorectic gut hormones such as peptide-YY (PYY) and glucagon-like peptide-1 (GLP-1)by the L cells of the distal gut and the suppression of the orexigenic hormone ghrelin released by the stomach.Obese people have a blunted rise in PYY and GLP-1 after a meal, possibly resulting in impaired satiety and hence greater food intake.
- In the present study the investigators sought to evaluate the effects of the resection of the gastric fundus, the main source of ghrelin production, on the secretion of ghrelin, PYY, GLP-1 and insulin and in addition on glucose levels, appetite and weight loss, in morbidly obese patients undergoing laparoscopic Roux-en-Y gastric bypass.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Twenty four patients were included prospectively in the study. After randomization, 12 patients underwent LRYGBP and 12 LRYGBP plus gastric fundus resection (LRYGBP+FR).
All human studies were performed according to the principles of the Declaration of Helsinki. The local Research and Ethics Commitee at the University Hospital of Patras approved the study. Written informed consent was obtained from all patients.
All the operations were performed by the same surgeon laparoscopically. The RYGBP procedures were performed creating a small isolated lesser curve-based gastric pouch (20 ± 5 ml) and a 150cm Roux limb. The gastroenteroanastomosis was conducted with a 25 mm circular stapler. The dissection of the fundus of the stomach in the (LRYGBP+FR) group was done with the use of EndoGia No 60.
The subjects were studied before and at 3, 6 and 12 months after the operation. All the patients underwent an oral glucose tolerance test (OGTT) with 75 g glucose, preoperatively. In addition, venous blood was collected after an overnight 12 hour fast and 30, 60 and 120 min after the administration of a 300 kcal mixed meal.The meal was consumed in ten minutes and consisted of 18% protein, 55% carbohydrate and 27% fat (Resource energy drink, Nestle Nutrition, France). Plasma levels of PYY, GLP-1, ghrelin and insulin were determined at every time point of the study. All patients underwent complete clinical evaluation during follow-up including nutritional, behavioral and anthropometric parameters. Visual analogue scales (VAS) were used to measure hunger, nausea, fullness and aversion to food, before and 30, 60 and 120 min after the consumption of the meal. Weight loss evaluation was based on postope¬rative body weight, body mass index (BMI) and % excess weight loss (EWL %).
Insulin resistance was approximated using the homeostatic model assessment for insulin resistance (HOMA IR). The following formula was used in its calculation:
HOMA IR = (fasting glucose [mmole] /lt X fasting insulin [μU/ml])/22.5). The insulinogenic index, a commonly used indicator of pancreatic β-cell function, was calculated as the ratio of increment of insulin concentrations to that of glucose concentrations at 30 minutes after meal ingestion (Δ [ins30 - ins0] / Δ [Glu30 -Glu0]).
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Achaia
-
Rion, Achaia, Greece, 26500
- University Hospital of Patras
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Body mass index higher than 40 kg/m2
Exclusion Criteria:
- pregnancy
- diabetes mellitus
- substance abuse
- chronic medical or psychiatric illness
- previous gastrointestinal surgery
Study Plan
How is the study designed?
Design Details
- Primary Purpose: BASIC_SCIENCE
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
ACTIVE_COMPARATOR: Roux-en-Y gastric bypass (LRYGBP)
Twelve subjects underwent laparoscopic Roux-en-Y gastric bypass
|
Twelve patients underwent laparoscopic Roux-en-Y gastric bypass
Other Names:
|
EXPERIMENTAL: LRYGBP plus gastric fundus resection
Twelve patients underwent laparoscopic Roux-en-Y gastric bypass plus gastric fundus resection
|
Twelve patients underwent laparoscopic Roux-en-Y gastric bypass and gastric fundus resection
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
The effects of the resection of the gastric fundus on the secretion of ghrelin, PYY, GLP-1 and insulin.
Time Frame: The outcome was assessed 12 months after the operation
|
The effect on the secretion of ghrelin, PYY, GLP-1 and insulin
|
The outcome was assessed 12 months after the operation
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
The effects of the resection of the gastric fundus on glucose levels, appetite and weight loss
Time Frame: At 12 months after the operation
|
The effect of fundus resection on glucose levels, appetite and weight loss was assessed 12 months after the operation
|
At 12 months after the operation
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Theodore K Alexandrides, Professor of Medicine, School of Medicine, University of Patras
Study record dates
Study Major Dates
Study Start
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- RYGBPFR001
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Morbid Obesity
-
ClinTrio Ltd.UnknownMorbid Obesity Requiring Bariatric SurgeryBelgium, Germany, Portugal, Austria, Netherlands, Poland, Saudi Arabia
-
Centre Hospitalier Universitaire de NiceCompletedMorbid Obesity D009765France
-
Shanghai Jiao Tong University School of MedicineUnknown
-
Hospices Civils de LyonCentre de Recherche en Nutrition Humaine Rhone-Alpe; Institut National de Recherche... and other collaboratorsRecruiting
-
Endolumik, IncWest Virginia UniversityNot yet recruitingMorbid ObesityUnited States
-
Rijnstate HospitalRecruiting
-
Laval UniversityCentre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie...Recruiting
-
University of WashingtonUnited States Department of DefenseWithdrawn
-
Helsinki University Central HospitalActive, not recruiting
-
IHU StrasbourgWithdrawnMorbid Obesity
Clinical Trials on Roux-en-Y gastric bypass (LRYGBP)
-
University Hospital, LilleMinistry of Health, FranceRecruitingDiabetes Mellitus Type 2 in ObeseFrance
-
CARLOS ZERRWECK LOPEZCompletedRoux-en-Y Gastric Bypass | Bariatric Surgery | Metabolic SurgeryMexico
-
CARLOS ZERRWECK LOPEZCompletedObesity | Bariatric Surgery Candidate | Type2 Diabetes | Laparoscopic Gastric BypassMexico
-
Spital Limmattal SchlierenUnknownObesity | Bypass ComplicationsSwitzerland
-
Hvidovre University HospitalUnknownObesity | Bone Loss | Gastric Bypass SurgeryDenmark
-
Hospital Universitario Virgen de la ArrixacaUnknown
-
Instituto Nacional de Ciencias Medicas y Nutricion...Completed
-
University of Roma La SapienzaCompleted
-
Marco BueterDr. Alan Spector, Florida State University, Department of PsychologyCompletedObesity | Bariatric Surgery | Ingestive Behavior | Food Deprivation | Roux-en-y Gastric Bypass | Ingestive Microstructure | DrinkometerSwitzerland
-
Marco BueterDepartment of Psychology and Program in Neuroscience, Florida State University...CompletedDrinking Behavior | Obesity, Morbid | Bariatric Surgery | Food Deprivation | Roux-en-y Gastric Bypass | Ingestive Microstructure | Drinkometer | MealSwitzerland